Skip to main content

Thomas Stinchcombe

Thomas Stinchcombe MD, is a Professor of Medicine, Duke Cancer Institute, NC, USA. His clinical interest is in thoracic malignancies, and his research focus is clinical trials for non-small cell and small cell lung cancer. He is a member of Duke Cancer Institute and the Thoracic Oncology Program at Duke University, Durham, NC.

print
PRINT

Latest contributions from Thomas Stinchcombe

Immunotherapy/maintenance therapy

09-10-2019 | Non-small-cell lung cancer | Editorial | Article

Current therapies for advanced NSCLC: The role of maintenance therapy in an immunotherapy world

Thomas Stinchcombe (Duke Cancer Institute, USA) examines the development of maintenance regimens and where they fit as immunotherapy continues to change treatment paradigms for NSCLC.